Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 6, 2010, Pages 1602-1609

  Heffernan, Daithi S ^a   Inaba, Kenji ^b   Arbabi, Saman ^c   Cotton, Bryan A ^d  

^a BROWN UNIVERSITY   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DIHYDROERGOTAMINE; ESMOLOL; METOPROLOL; PHENTOLAMINE; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

AGITATION; BLOOD PRESSURE REGULATION; BONE METABOLISM; BRAIN ISCHEMIA; CAPILLARY PRESSURE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIAPHORESIS; DYSTONIA; ELECTROCARDIOGRAM; ENDOTOXEMIA; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTRACRANIAL HYPERTENSION; NONHUMAN; PAROXYSMAL SYMPATHETIC STORM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; ST SEGMENT DEPRESSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T WAVE INVERSION; TACHYCARDIA; TACHYPNEA; TRAUMATIC BRAIN INJURY; VAGUS NERVE; VAGUS NERVE STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; HUMANS; SYMPATHETIC NERVOUS SYSTEM;

EID: 78650821423     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181f2d3e8     Document Type: Review

References (89)

1. Acosta J, Yang J, Winchell R, et al. Lethal injuries and time to death in a level 1 trauma center. J Am Coll Surg. 1998;186:528-533.
2. Cales R, Trunkey D. Preventable trauma deaths. A review of trauma care systems development. JAMA. 1985;254:1059-1063.
3. Kemp C, Johnson J, Riordan W, Cotton BA. How we die: the impact of non-neurological organ dysfunction after severe traumatic brain injury. Am Surg. 2008;74:866-872.
4. Zygun D, Kortbeek J, Fick G, Laupland KB, Doig CJ. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33:654-660. (Pubitemid 40365570)
5. Piek J, Chesnut R, Marshall L, et al. Extracranial complications of severe head injury. J Neurosurg. 1992;77:901-907.
6. Penfield W. Diencephalic autonomic epilepsy. Arch Neurol. 1929;22: 358-374.
7. Rossitch E, Bullard D. The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg. 1988;2:471-478.
8. Baguley I, Heriseanu R, Cameron I, Nott MT, Slewa-Younan S. A Critical review of the pathophysiology of Dysautonomia following traumatic brain injury. Neurocrit Care. 2008;8:293-300.
9. Pranzatelli M, Pavlakis S, Gould R, De Vivo DC. Hypothalamicmidbrain dysregulation syndrome: hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol. 1991;6:115-122.
10. Blackman J, Patrick P, Buck M, Rust RS Jr. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol. 2004;61:321-328. (Pubitemid 38327347)
11. Baguley I. The excitatory:inhibitory ratio model (EIR model): an integrative explanation of acute autonomic overactivity syndromes. Med Hypotheses. 2008;70:26-35.
12. Baguley I, Heriseanu R, Felmingham K, Cameron ID. Dysautonia and heart rate variability following severe traumatic brain injury. Brain Inj. 2006;20:437-444. (Pubitemid 43832369)
13. Crompton M. Hypothalamic lesions following closed head injury. Brain. 1971;94:165-172.
14. Bullard D. Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol. 1987;21:609-611.
15. Boeve B, Wijdicks E, Benarroch E, Schmidt KD. Paroxysmal sympathetic storms ("diencephalic seizures") after sever diffuse axonal head injury. Mayo Clin Proc. 1998;73:148-152.
16. Nosuka S. Hypertension induced by extensive medial anteromedian hypothalamic destruction in the rat. Jpn Circ J. 1966;30:509-523.
17. Reis D, Gauthier P, Nathan M. Hypertension, Adrenal Catecholamine Release, Pulmonary Edema, and Behavioral Excitement Elicited from the Anterior Hypothalamus in Rat. Elmsford, NY: Pergamon Press; 1976.
18. Noredi S, Lambert G, Eden E, et al. Increased sympathetic nervous activity in patients with nontraumatic subrachnoid hemorrhage. Stroke. 2000;31:901-906.
19. Woolf P, McDonald J, Feliciano D, Kelly MM, Nichols D, Cox C. The catecholamine response to multisystem trauma. Arch Surg. 1992;127: 899-903.
20. Kupferman I. Hypothalamus and Limbic System, II: Motivation. New York, NY: Elsevier Science Publishers; 1985.
21. Clifton G, Ziegler M, Grossman R. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery. 1981;8:10-14.
22. Jachuck S, Ramani P, Clark F, Kalbag RM. Electrocardiographic abnormalities associated with raised intracranial pressure. Br Med J. 1975;1:242-244.
23. Neil-Dwyer G, Walter P, Cruickshank J, Doshi B, O'Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2:990-992.
24. Randell T, Tanskanen P, Scheinin M, Kytta J, Ohman J, Lindgren L. QT depression after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11:163-166.
25. Harari A, Rapin M, Regnier B, Comoy J, Caron JP. Normal pulmonarycapillary pressures in the late phase of neurogenic pulmonary oedema. Lancet. 1976;1:494.
26. Smith W, Matthay M. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest. 1997;111:1326-1333.
27. Cruickshank J, Neil-Dwyer G, Stott A. Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid haemorrhage. Br Heart J. 1974;36:697-703.
28. Greenhoot J, Reichenbach D. Cardiac injury and subarachnoid hemorrhage. A clinical, pathological and physiological correlation. J Neurosurg. 1969;30:521-531.
29. Neil-Dwyer G, Cruickshank J, Stratton C. Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhage. Surg Neurol. 1986;25:163-168.
30. Sparks H, Hollenberg M, Carriere S, Funkenstein D, Zakheim RM, Barger AC. Sympathomimetic drugs and repolarization of ventricular myocardium of the dog. Cardiovasc Res. 1970;4:363-370.
31. Maling H, Highman B. Exaggerated ventricular arrhythmias and myocardia fatty changes after large doses of norepinephrine and epinephrine in unanesthetized dogs. Am J Physiol. 1958;194:590-596.
32. Poulat P, Couture R. Increased pulmonary vascular permeability and oedema induced by intrathecally injected endothelins in rat. Eur J Pharmacol. 1998;344:251-259.
33. Parr M, Finfer S, Morgan M. Reversible cardiogenic shock complicating subarachnoid haemorrhage. Br Med J. 1996;313:681-683.
34. Sasaki M, Dunn L. A model of acute subdural hematoma in the mouse. J Neurotrauma. 2001;18:1241-1246.
35. Roe S, Rothwell N. Whole body metabolic responses to brain trauma in the rat. J Neurotrauma. 1997;14:399-408.
36. Chiolero R, Breitenstein E, Thorin D, et al. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med. 1989; 17:328-334. (Pubitemid 19108363)
37. Foley N, Marshall S, Pikul J, Salter K, Teasell R. Hypermetabolism following moderate to severe traumatic acute brain injury: a systemic review. J Neurotrauma. 2008;25:1415-1431.
38. Robertson C, Clifton G, Grossman R. Oxygen utilization and cardiovascular function in head-injured patients. Neurosurgery. 1984;15: 307-314.
39. Woiciechowsky C, Asadullah K, Nestler D, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808-813.
40. Deng J, Muthu K, Gamelli R, Shankar R, Jones SB. Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am J Physiol Cell Physiol. 2004;287:C730-C736.
41. Ley E, Scehnet J, Park R, et al. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009;66:154-161.
42. Lui M. Protective effects of propranolol on experimentally head injured mouse brains. J Formos Med Assoc. 1995;94:386-390.
43. McLean K, Pandalai P, Pearl J, et al. Beta-adrenergic receptor antagonism preserves myocardial function after brain death in a porcine model. J Heart Lung Transplant. 2007;26:522-528.
44. Tracey K. The inflammatory reflex. Nature. 2002;420:853-859.
45. Tracey K. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289-296.
46. Borovikova L, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.
47. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor Alpha-7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-388.
48. Pavlov V, Ochani M, Gallowitsch-Puerta M, et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA. 2006;103:5219-5223.
49. Wang H, Fitzgerald R. Muscarinic modulation of hypoxia-induced release of catecholamines from the cat caroitd body. Brain Res 2002; 927:122-137.
50. Neubauer J, Sunderam J. Oxygen sensing neurons in the central nervous system. J Appl Physiol. 2004;96:367-374.
51. Han R-Q, Ouyang Y-B, Xu L, Agrawal R, Patterson AJ, Giffard RG. Postischemic brain injury is attenuated in mice lacking the beta2- adrenergic receptor. Anesth Analg. 2009;108:280-287.
52. Linnik M, Zobrist R, Hatfield M. Evidence supporting a role for programed cell death in focal ischemia in rats. Stroke. 1994;24:2002-2009.
53. Du C, Hu R, Csernansky C, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab. 1996;16:195-201.
54. Savitz S, Erhardt J, Anthony J, et al. The novel beta-blocker, carvediol, provides neurprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;20:1197-1204.
55. Hortnagl H, Hammerle R, Hackl J, Brücke T, Rumpl E, Hörtnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med. 1980;6:169-177.
56. Asgeirsson B, Grande P, Nordstrom C, Berntman L, Messeter K, Ryding E. Effects of hypotensive treatment with alpha 2-agonist and beta 1-agonist on cerebral haemodynamics in severely head injured patients. Acta Anesthesiol Scand. 1995;39:347-351.
57. Hoffman W, Cheng M, Thomas C, Baughman VL, Albrecht RF. Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg. 1991;73:460-464.
58. Asgeirsson B, Grande P, Nordstrom C. A new therapy for post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med. 1994;20:260-267.
59. Grande P, Asgeirsson B, Nordstrom C. Physiological principles for volume regulation of a tissue enclosed in a rigid shelter with application to the injured brain. J Trauma. 1997;42(5 suppl):S23-S31.
60. Walter P, Neil-Dwyer G, Cruickshank J. Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. Br Med J. 1982;284:1661-1664.
61. Herndon D, Hart D, Wolf S, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001; 345:1223-1229.
62. Kulp G, Herndon D, Lee J, Suman OE, Jeschke MG. Extent and magnitude of catecholamine surge in pediatric burned patients. Shock. 2010;33:369-374.
63. Pereira C, Jeschke M, Herndon D. Beta-blockade in burns. Novartis Found Symp. 2007;280:238-248.
64. Ballard-Croft C, Maass D, Sikes P, White J, Horton J. Activation of the stress-responsive pathways by the sympathetic nervous system in burn trauma. Shock. 2002;18:38-45.
65. Gosain A, Jones S, Shankar R, Gamelli RL, DiPietro LA. Norepinephrine modulates the inflammatory and proliferative phases of wound healing. J Trauma. 2006;60:736-744.
66. Murphy K, Lee J, Herndon D. Current pharmacotherapy for the treatment of severe burns. Expert Opin Pharmacother. 2003;4:369-384.
67. Herndon D, Nguyen T, Wolfe R, et al. Lipolysis in burned patients is stimulated by the beta2-receptor for catecholamines. Arch Surg. 1994; 129:1301-1304.
68. Pereira C, Murphy K, Jeschke M, Herndon DN. Post-burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005; 37:1948-1961.
69. Easton J, Sherman D. Somatic anxiety attacks and propranolol. Arch Neurol. 1976;33:689-691.
70. Brooke M, Patterson D, Questad K, Cardenas D, Farrel-Roberts L. The treatment of agitation during initial hospitalization after traumatic brain injury. Arch Phys Med Rehabil. 1992;73:917-921.
71. Greendyke R, Kanter D, Schuster D, Verstreate S, Wootton J. Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study. J Nerv Ment Dis. 1986;174:290-294.
72. Cruickshank J, Neil-Dwyer G, Degaute J, et al. Reduction of stress/ catecholamine-induced cardiac necrosis by beta 1-selective blockade. Lancet. 1987;12:585-589.
73. Cotton B, Snodgrass K, Fleming S, et al. Beta-blocker exposure is associated with imporved survival after severe traumatic brain injury. J Trauma. 2007;62:26-33.
74. Arbabi S, Campion E, Hemmila M, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;61: 56-61.
75. Inaba K, Teixeira P, David J-S, et al. Beta-blockers in isolated blunt head injury. J Am Col Surg. 2008;206:432-438.
76. Neideen T, Lam M, Brasel K. Preinjury beta blockers are associated with increased mortality in geriatric trauma patients. J Trauma. 2008; 65:1016-1020.
77. Su C, Kuo T, Kuo J, Lai HY, Chen HI. Sympathetic and parasympathetic activities evaluated by heart rate variability in head injury of various severities. Clin Neurophysiol. 2005;116:1273-1279.
78. Grogan E, Morris J, Norris P, et al. Reduced heart rate volatility: an early predictor of death in trauma patients. Ann Surg. 2004;240:547-554.
79. Mowery N, Norris P, Riordan W, Jenkins JM, Williams AE, Morris JA Jr. Cardiac uncoupling and heart rate variability are associated with intracranial hypertension and mortality: a study of 145 trauma patients with continuous monitoring. J Trauma. 2008;65:621-627.
80. Rapenne T, Moreau D, Lenfant F, et al. Could heart rate variability predict outcome in patients with severe head injury? A pilot study. J Neurosurg Anesthesiol. 2001;13:260-268.
81. Lowensohn R, Weiss M, Hon E. Heart-rate variability in brain damaged adults. Lancet. 1977;19:626-628.
82. Goldstein B, Kempski M, DeKing D, et al. Autonomic control of heart rate after brain injury in children. Crit Care Med. 1996;24:234-240.
83. Goldstein B, DeKing D, DeLong D, et al. Autonomic cardiovascular state after severe brain injury and brain death in children. Crit Care Med. 1993;21:228-233.
84. Riordan B, Cotton B, Norris P, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503-510.
85. Riordan B, Norris P, Jenkins J, Morris JA Jr. Early loss of heart rate complexity predicts mortality regardless of mechanism, anatomic location, or severity of injury in 2178 trauma patients. J Surg Res. 2009;156:283-289.
86. Snodgrass K, Fleming S, Cotton B. Survival benefit of beta-blockers in severe TBI is associated with a reduction in heart rate. Crit Care Med. 2006;34:A53.
87. DiAngelantonio E, Fiorelli M, Toni D, et al. Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. Journal of Neurol Neurosurg Psychiatry. 2005;76:76-81.
88. Hays A, Diringer M. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology. 2006; 66:1296-1297.
89. Salim A, Hadjizacharia P, Brown C, et al. Significance of troponin elevation after severe traumatic brain injury. J Trauma. 2008;64: 46-52.